Showing results (251-260 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|September 19, 2025
Sustainable anticoagulation for climate resilient careBingwen Eugene Fan, Kevin Milla, Scott McAlister, et al.
The Lancet. Haematology|October 11, 2025
Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trialGuillaume Richard-Carpentier, Gopila Gupta, Charina Koraksic, et al.
The Lancet. Haematology|August 6, 2025
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trialMaría-Victoria Mateos, Bruno Paiva, M Teresa Cedena, et al.
The Lancet. Haematology|August 6, 2025
A multimodal sexual dysfunction intervention versus enhanced usual care for survivors of haematopoietic stem-cell transplantation: a single-centre, open-label, randomised clinical trialAreej El-Jawahri, Lara Traeger, Jennifer B Reese, et al.
The Lancet. Haematology|March 8, 2016
Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trialSarit Assouline, Valeria Buccheri, Alain Delmer, et al.
The Lancet. Haematology|October 6, 2015
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 studyPreetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.
The Lancet. Haematology|February 9, 2016
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trialYlva Haig, Tone Enden, Ole Grøtta, et al.
The Lancet. Haematology|February 9, 2016
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysisValentino Conter, Maria Grazia Valsecchi, Barbara Buldini, et al.
The Lancet. Haematology|November 19, 2017
Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational studyAndrea Penaloza, Caroline Soulié, Thomas Moumneh, et al.
The Lancet. Haematology|October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Pageof 73